ARTHRYL 1500 mg/1 kesica prašak za oralni rastvor Bosnien och Hercegovina - kroatiska - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

arthryl 1500 mg/1 kesica prašak za oralni rastvor

viatris bh d.o.o. - glukozamin - prašak za oralni rastvor - 1500 mg/1 kesica - jedna kesica sadrži: 1884 mg glukozamin sulfat natrijum hlorida (što odgovara 1500 mg glukozamin sulfata)

ARTHRYL 750 mg/1 tableta filmom obložena tableta Bosnien och Hercegovina - kroatiska - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

arthryl 750 mg/1 tableta filmom obložena tableta

viatris bh d.o.o. - glukozamin - filmom obložena tableta - 750 mg/1 tableta - jedna filmom obložena tableta sadrži: 942,00 mg glukozamin sulfat natrijev hlorida (što odgovara 750 mg glukozamin sulfata)

Hyplaxy 200 mg filmom obložene tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

hyplaxy 200 mg filmom obložene tablete

makpharm d.o.o., trnjanska cesta 37/1, zagreb, hrvatska - hidroksiklorokin sulfat - filmom obložena tableta - 200 mg - urbroj: jedna filmom obložena tableta sadrži 200 mg hidroksiklorokin sulfata

Lyumjev (previously Liumjev) Europeiska unionen - kroatiska - EMA (European Medicines Agency)

lyumjev (previously liumjev)

eli lilly nederland b.v. - inzulin lispro - Šećerna bolest - lijekovi koji se koriste u dijabetesu - liječenje dijabetes melitusa kod odraslih, adolescenata i djece u dobi od 1 godine i više. liječenje dijabetes melitusa kod odraslih.

AMIKACIN SOPHARMA 500 mg/2 mL otopina za injekciju/ infuziju Bosnien och Hercegovina - kroatiska - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

amikacin sopharma 500 mg/2 ml otopina za injekciju/ infuziju

unifarm d.o.o. lukavac - Амикацин - otopina za injekciju/ infuziju - 500 mg/2 ml - 1 ampula sa 2 ml otopine za injekciju/infuziju sadrži: 500 mg amikacina (u obliku amikacin sulfata)

Comirnaty Europeiska unionen - kroatiska - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Jcovden (previously COVID-19 Vaccine Janssen) Europeiska unionen - kroatiska - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - cjepiva - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Europeiska unionen - kroatiska - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - cjepiva - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.